Violett kills germs in the air 50 times more effectively than comparable products using our patent-pending air handling technology. We have an opportunity to reduce or eliminate airborne disease transmission by properly deploying Violett technology to the places we live, work, play and breathe. Tested against SARS-CoV-2 (Covid-19 virus) and highly effective against all other known airborne germs, Violett allows the world to breathe safely.Violett is an early stage company, but growing quickly. We have launched a Beta program, with initial customers in elder care, medical, and education spaces (early childhood - university). We are focusing our efforts in those areas most impacted by the Covid-19 pandemic, and want to do our part to help the most vulnerable. Want to join our Beta program? Let us know! We are actively looking for the next places to deploy our technology that will have the highest impact.Interested in how you can contribute to Violett's mission? Please connect to discuss upcoming opportunities!